Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Kunitaka, Fukuizumi"'
Autor:
Hideki, Iwamoto, Takashi, Niizeki, Hiroaki, Nagamatsu, Kazuomi, Ueshima, Takako, Nomura, Teiji, Kuzuya, Kazuhiro, Kasai, Yohei, Kooka, Atsushi, Hiraoka, Rie, Sugimoto, Takehiro, Yonezawa, Akio, Ishihara, Akihiro, Deguchi, Hirotaka, Arai, Shigeo, Shimose, Tomotake, Shirono, Masahito, Nakano, Shusuke, Okamura, Yu, Noda, Naoki, Kamachi, Miwa, Sakai, Hiroyuki, Suzuki, Hajime, Aino, Norito, Matsukuma, Satoru, Matsugaki, Kei, Ogata, Yoichi, Yano, Takato, Ueno, Masahiko, Kajiwara, Satoshi, Itano, Kunitaka, Fukuizumi, Hiroshi, Kawano, Kazunori, Noguchi, Masatoshi, Tanaka, Taizo, Yamaguchi, Ryoko, Kuromatsu, Atsushi, Kawaguchi, Hironori, Koga, Takuji, Torimura, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan
Publikováno v:
Cancers
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
BACKROUND: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f1483325e31a608b20b62e39c0d540
https://pubmed.ncbi.nlm.nih.gov/33562793
https://pubmed.ncbi.nlm.nih.gov/33562793
Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism
Autor:
Masaki Kato, Atsushi Nakajima, Yuichi Nozaki, Tsukasa Nakamura, Kunitaka Fukuizumi, Kazuhiro Kotoh, Ryoko Yada, Makoto Nakamuta, Yoshihiko Maehara, Motoyuki Kohjima, Yusuke Murata, Ken Shirabe, Akira Honda, Nobuyoshi Fukushima, Tsuyoshi Yoshimoto, Munechika Enjoji, Manabu Nakashima, Yasushi Matsuzaki
Publikováno v:
Liver International. 35:1095-1102
Background & Aims Injury to biliary epithelial cells caused by disorders in bile composition may be the initial step in the pathogenesis of primary biliary cirrhosis (PBC). We therefore examined choline/phospholipid metabolism in livers of patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67dad025a14bc202fbd920c162e45284
https://doi.org/10.1111/liv.12526
https://doi.org/10.1111/liv.12526
Autor:
Munechika Enjoji, Makoto Nakamuta, Tsuyoshi Yoshimoto, Yusuke Murata, Kazuhisa Matsunaga, Miho Kurokawa, Masaki Kato, Naohiko Harada, Tomoko Ohashi, Kunitaka Fukuizumi, Tsukasa Nakamura, Kazuhiro Kotoh, Motoyuki Kohjima
Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7347d79eb1fc2814f27980965573f43e
https://europepmc.org/articles/PMC4840744/
https://europepmc.org/articles/PMC4840744/
Autor:
Yasuhito Tanaka, Kazuhiro Kotoh, Makoto Nakamuta, Tsuyoshi Yoshimoto, Motoyuki Kohjima, Munechika Enjoji, Kunitaka Fukuizumi, Yoko Aoyagi, Manabu Nakashima, Naoya Sakamoto, Tatsuya Fujino, Masayoshi Yada, Masaki Kato, Naohiko Harada, Nobuyoshi Fukushima, Ryoko Yada
Publikováno v:
Journal of Medical Virology. 85:250-260
Despite the use of pegylated-interferon (peg-IFN) plus ribavirin combination therapy, many patients infected with hepatitis C virus (HCV)-1b remain HCV-positive. To determine whether addition of pitavastatin and eicosapentaenoic acid (EPA) is benefic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c442829c2f292f1f0fbd73fbf0d8ce
https://doi.org/10.1002/jmv.23464
https://doi.org/10.1002/jmv.23464
Autor:
Osami Inoue, Satoshi Ohta, Akinobu Taketomi, Akinari Tabaru, Kunitaka Fukuizumi, Kenji Takenaka, Kenji Nagata, Tatsuyuki Kakuma, Takumi Kawaguchi, Tatsuji Maeshiro, Hideki Saitsu, Hirohito Tsubouchi, Motoo Akahoshi, Toshihiko Mizuta, Kazuhiko Nakao, Hiroshi Yatsuhashi, Masataka Seike, Toyokichi Muro, Hiroshi Watanabe, Yasuji Komorizono, Shuichi Matsumoto, Michio Sata
Publikováno v:
Hepatology Research. 41:564-571
Aim: Non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma (NBNC-HCC) is often detected at an advanced stage, and the pathology associated with the staging of NBNC-HCC remains unclear. Data mining is a set of statistical techni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5934a0445eb1e0974486e956c0c35c96
https://doi.org/10.1111/j.1872-034x.2011.00799.x
https://doi.org/10.1111/j.1872-034x.2011.00799.x
Autor:
Munechika Enjoji, Y. Maehara, Tsuyoshi Yoshimoto, Naohiko Harada, Yoko Aoyagi, Manabu Nakashima, Kazuhiro Kotoh, Motoyuki Kohjima, Masaki Kato, Ryoko Yada, Kunitaka Fukuizumi, Akinobu Taketomi, Masayoshi Yada, M. Nakamuta, Tatsuya Fujino, Kenichiro Yasutake
Publikováno v:
Journal of Medical Virology. 83:921-927
Recent studies have demonstrated that several cellular factors are involved in entry of hepatitis C virus (HCV) into host cells. Detailed gene expression profiles of these factors in HCV-infected livers have not been reported for humans. Transcriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58005bd433f561b9296314868b59fa84
https://doi.org/10.1002/jmv.22042
https://doi.org/10.1002/jmv.22042
Autor:
Naohiko Harada, Ryosuke Takemoto, Makoto Nakamuta, Toshihiko Miyahara, Tsuyoshi Yoshimoto, Kotaro Koga, Kenichiro Yasutake, Hideki Saitsu, Kunitaka Fukuizumi, Manabu Nakashima, Munechika Enjoji, Yuko Takami, Yoshiyuki Wada, Yoko Aoyagi, Tatsuya Fujino
Publikováno v:
Journal of Digestive Diseases. 10:145-148
OBJECTIVE: The aim of this study was to validate the FibroScan system compared with liver histology and serum markers for the diagnosis of hepatic fibrosis. We also tried to determine the cut-off levels and assess the feasibility of using FibroScan v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1a7fb3eb1bae5c1b2ce6b5043b83a4
https://doi.org/10.1111/j.1751-2980.2009.00377.x
https://doi.org/10.1111/j.1751-2980.2009.00377.x
Autor:
Tsuyoshi Yoshimoto, Toshihiko Miyahara, Manabu Nakashima, Munechika Enjoji, Tatsuya Fujino, Kunitaka Fukuizumi, Yoko Aoyagi, Makoto Nakamuta, Hironori Sakai, Naohiko Harada, Ryosuke Takemoto
Publikováno v:
Journal of Digestive Diseases. 10:21-25
OBJECTIVE: Pegylated interferon (PEG-IFN) plus ribavirin (RBV) combination therapy is now a popular treatment for patients with chronic hepatitis C; however, the reported sustained virologic response (SVR) rate remains at nearly 50% in genotype 1b in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3412456f0c7d4f9aa84aa460cff15e69
https://doi.org/10.1111/j.1751-2980.2008.00358.x
https://doi.org/10.1111/j.1751-2980.2008.00358.x
Autor:
Makoto Nakamuta, Tsuyoshi Yoshimoto, Manabu Nakashima, Munechika Enjoji, Noriko Haruta, Kenichiro Yasutake, Kaori Masuda, Yoko Aoyagi, Yuki Shima, Akiko Ohyama, Kunitaka Fukuizumi, Naohiko Harada, Ryosuke Takemoto, Fukuko Hayata, Toshihiko Miyahara, Tatsuya Fujino
Publikováno v:
Scandinavian Journal of Gastroenterology. 44:471-477
The onset and progression of non-alcoholic fatty liver disease (NAFLD) seem to be affected by nutritive intake; however, detailed examinations have not been performed in non-obese NAFLD patients. The purpose of this study was to identify potential nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53529ad89212d4e993a8fee1930d4c82
https://doi.org/10.1080/00365520802588133
https://doi.org/10.1080/00365520802588133
Autor:
Yorinobu Sumida, Tsukasa Nakamura, Yusuke Sasaki, Yasushi Shimonaka, Kazuhiro Kotoh, Yusuke Murata, Susumu Koyama, Makoto Nakamuta, Munechika Enjoji, Kazuhiro Haraguchi, Kunitaka Fukuizumi, Masaki Kato, Ken Kawabe, Miho Kurokawa, Nao Fujimori, Naohiko Harada, Nobuyoshi Fukushima, Motoyuki Kohjima, Tsuyoshi Yoshimoto
Publikováno v:
World journal of gastroenterology. 21(11)
AIM: To investigate the relationship between the iron-metabolism-related gene expression profiles and efficacy of antiviral therapy in chronic hepatitis C patients. METHODS: The hepatic expression profile of iron-metabolism-related genes was analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db30f65308603c722f39dde4354b77e3
https://pubmed.ncbi.nlm.nih.gov/25805936
https://pubmed.ncbi.nlm.nih.gov/25805936